Defining the mechanisms regulating MLLT3 expression in human hematopoietic stem cells
定义人类造血干细胞中 MLLT3 表达的调节机制
基本信息
- 批准号:10113603
- 负责人:
- 金额:$ 28.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-03-16 至 2022-12-31
- 项目状态:已结题
- 来源:
- 关键词:BindingBioinformaticsBiologyBlood CellsCRISPR/Cas technologyCell Culture TechniquesChIP-seqChromatinClinicalDataDevelopmentEVI1 geneEngineeringEngraftmentEnhancersEpigenetic ProcessExperimental ModelsFetal LiverFutureGene ExpressionGenerationsGenesGenetic Enhancer ElementGoalsHematological DiseaseHematopoiesisHematopoietic Stem Cell TransplantationHematopoietic stem cellsHigh-Throughput Nucleotide SequencingHistonesHumanImmunologicsIn VitroIndividualKDM1A geneLeadLentivirus VectorLifeLysineMLLT3 geneMaintenanceMalignant - descriptorMediatingModificationMonitorMusNamesPatientsProtein IsoformsProteinsProtocols documentationRegenerative MedicineRegulationRegulator GenesRegulatory ElementReporterRepressionReverse Transcriptase Polymerase Chain ReactionRoleSavingsSecond Pregnancy TrimesterTestingTetanus Helper PeptideTimeTranscriptTranscription Initiation SiteTranscriptional Elongation FactorsUmbilical Cord Bloodaptamerbaseblood formationcell typeepigenome editinggain of functionhematopoietic stem cell expansionhematopoietic stem cell self-renewalhematopoietic tissuehemogenic endotheliumhigh throughput analysishuman RNA sequencinghuman embryonic stem cellimprovedin vivoinsightnovelnovel strategiesoverexpressionp300/CBP-Associated Factorpopulation basedprogramsrecruitself-renewalsingle-cell RNA sequencingstem cell functionstem cell therapystemnesssuccesstransplantation therapy
项目摘要
SUMMARY
Hematopoietic stem cells (HSCs) sustain life-long blood formation due to their ability to self-renew and
differentiate into all mature blood cell types (referred to as “stemness”). Transplantation of HSC-containing grafts
is a life-saving therapy for multiple blood disorders; however, shortage of immunologically matched donors limits
the number of patients that can be treated. Expansion/generation of human HSCs in culture would greatly
improve transplantation therapy but has been unsuccessful due to poor understanding of the underlying biology
of HSC stemness. We identified MLLT3 as HSC regulator that is highly enriched in human HSC at all stages
once they have emerged from AGM and expand in the fetal liver (FL); however, MLLT3 expression declines in
cultured HSC. Loss and gain of function studies on human FL and cord blood (CB) HSCs showed that MLLT3 is
critical for their self-renewal, and when its expression is restored, it enables HSC expansion in culture by
protecting their “stemness” program. Importantly, FL and CB HSC expanded in culture showed 10-30 fold
increase in human engraftment in NSG mice, and ability to sustain the HSPC compartment and multilineage
hematopoiesis without malignant transformation or differentiation block. This finding offers an unprecedented
opportunity to understand how human HSC stemness is controlled, and harness MLLT3 for clinical use. So far,
the regulatory mechanisms that govern MLLT3 expression in HSC are completely unknown. Using a combination
of epigenetic studies and bioinformatic approaches, we identified several candidate enhancers in MLLT3 gene
that may regulate its two isoforms. Our data suggests that these enhancers are epigenetically remodeled during
differentiation and silenced during HSC culture, providing new avenues to understand why cultured HSC lose
MLLT3 expression. To understand how MLLT3 expression is regulated in human HSCs, we propose two
complementary approaches: 1) CRISPR/Cas9-mediated epigenome editing to dissect the role of MLLT3
enhancers, 2) combination of bioinformatic and experimental approaches using lentiviral overexpression to
identify MLLT3 upstream regulators. Success in these approaches could help generate/expand human HSCs in
culture and thereby increase the availability of HSCs for transplantation.
总结
造血干细胞(HSC)由于其自我更新和再生的能力而维持终生的血液形成。
分化成所有成熟的血细胞类型(称为“干细胞”)。含HSC移植物的移植
是多种血液疾病的救命疗法;然而,缺乏免疫匹配的供体限制了
可以治疗的患者数量。在培养物中扩增/产生人HSC将极大地
但由于对潜在生物学的理解不足,
HSC的干性。我们将MLLT 3鉴定为HSC调节因子,其在所有阶段高度富集于人HSC中
一旦它们从AGM中出现并在胎肝(FL)中扩增,MLLT 3表达就会下降;然而,
培养的HSC。对人FL和脐带血(CB)HSC的功能丧失和获得研究表明,MLLT 3是
对于它们的自我更新至关重要,当其表达恢复时,它通过以下方式使HSC在培养中扩增:
保护他们的“sterness”计划重要的是,在培养中扩增的FL和CB HSC显示出10-30倍的扩增。
NSG小鼠中的人植入增加,以及维持HSPC隔室和多谱系的能力
造血无恶变或分化阻滞。这一发现提供了前所未有的
有机会了解人类HSC干性是如何控制的,并利用MLLT 3进行临床应用。到目前为止,
控制HSC中MLLT 3表达的调节机制完全未知。使用组合
通过表观遗传学研究和生物信息学方法,我们鉴定了MLLT 3基因的几个候选增强子
可以调节它的两种亚型。我们的数据表明,这些增强子是表观遗传重塑过程中,
在HSC培养过程中分化和沉默,提供了新的途径来了解为什么培养的HSC失去
MLLT 3表达。为了了解MLLT 3在人HSC中的表达是如何调节的,我们提出了两个
互补方法:1)CRISPR/Cas9介导的表观基因组编辑,以剖析MLLT 3的作用
增强子,2)使用慢病毒过表达的生物信息学和实验方法的组合,
识别MLLT 3上游调节子。这些方法的成功可以帮助在体外产生/扩增人HSC。
培养,从而增加用于移植的HSC的可用性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Hanna Katri Annikki Mikkola其他文献
Hanna Katri Annikki Mikkola的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Hanna Katri Annikki Mikkola', 18)}}的其他基金
MYCT1 as a moderator for signaling between human HSC and their niche
MYCT1 作为人类 HSC 与其生态位之间信号传导的调节剂
- 批准号:
10392239 - 财政年份:2022
- 资助金额:
$ 28.08万 - 项目类别:
MYCT1 as a moderator for signaling between human HSC and their niche
MYCT1 作为人类 HSC 与其生态位之间信号传导的调节剂
- 批准号:
10593103 - 财政年份:2022
- 资助金额:
$ 28.08万 - 项目类别:
Mapping human hematopoietic stem cell development
绘制人类造血干细胞发育图谱
- 批准号:
10435434 - 财政年份:2021
- 资助金额:
$ 28.08万 - 项目类别:
Mapping human hematopoietic stem cell development
绘制人类造血干细胞发育图谱
- 批准号:
10633115 - 财政年份:2021
- 资助金额:
$ 28.08万 - 项目类别:
Mapping human hematopoietic stem cell development
绘制人类造血干细胞发育图谱
- 批准号:
9998658 - 财政年份:2021
- 资助金额:
$ 28.08万 - 项目类别:
Defining the mechanisms regulating MLLT3 expression in human hematopoietic stem cells
定义人类造血干细胞中 MLLT3 表达的调节机制
- 批准号:
9766113 - 财政年份:2019
- 资助金额:
$ 28.08万 - 项目类别:
Defining the mechanisms regulating MLLT3 expression in human hematopoietic stem cells
定义人类造血干细胞中 MLLT3 表达的调节机制
- 批准号:
9894797 - 财政年份:2019
- 资助金额:
$ 28.08万 - 项目类别:
Defining the self-renewal program in human hematopoietic stem cells
定义人类造血干细胞的自我更新程序
- 批准号:
8934081 - 财政年份:2014
- 资助金额:
$ 28.08万 - 项目类别:
Defining the Self-Renewal Program in Human Hematopoietic Stem Cells
定义人类造血干细胞的自我更新程序
- 批准号:
10210386 - 财政年份:2014
- 资助金额:
$ 28.08万 - 项目类别:
Defining the Self-Renewal Program in Human Hematopoietic Stem Cells
定义人类造血干细胞的自我更新程序
- 批准号:
10443733 - 财政年份:2014
- 资助金额:
$ 28.08万 - 项目类别:
相似海外基金
Predoctoral Training in Bioinformatics and Computational Biology
生物信息学和计算生物学博士前培训
- 批准号:
10715126 - 财政年份:2023
- 资助金额:
$ 28.08万 - 项目类别:
UCLA Pediatric Research Education Program in Bioinformatics, Computational Biology, and Omics
加州大学洛杉矶分校生物信息学、计算生物学和组学儿科研究教育项目
- 批准号:
10629061 - 财政年份:2023
- 资助金额:
$ 28.08万 - 项目类别:
Using Computational Intelligence for Bioinformatics and Computational Biology
将计算智能用于生物信息学和计算生物学
- 批准号:
575765-2022 - 财政年份:2022
- 资助金额:
$ 28.08万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Master's
Graduate Training Program in Computational Biology, Bioinformatics and Biomedical Data Science (CBB)
计算生物学、生物信息学和生物医学数据科学研究生培训项目(CBB)
- 批准号:
10654859 - 财政年份:2022
- 资助金额:
$ 28.08万 - 项目类别:
Conference: Conference on Bioinformatics, Computational Biology, and Health Informatics 2022
会议:2022 年生物信息学、计算生物学和健康信息学会议
- 批准号:
2233805 - 财政年份:2022
- 资助金额:
$ 28.08万 - 项目类别:
Standard Grant
Systems Biology of Early Atopy (SUNBEAM) Analysis and Bioinformatics Center
早期特应性系统生物学(SUNBEAM)分析和生物信息学中心
- 批准号:
10573523 - 财政年份:2022
- 资助金额:
$ 28.08万 - 项目类别:
Systems Biology, Bioinformatics, & Data Integration
系统生物学、生物信息学、
- 批准号:
10459538 - 财政年份:2021
- 资助金额:
$ 28.08万 - 项目类别:
Systems Biology, Bioinformatics, & Data Integration
系统生物学、生物信息学、
- 批准号:
10653908 - 财政年份:2021
- 资助金额:
$ 28.08万 - 项目类别:
MCA: Application of Quantum Computing in Bioinformatics and Computational Biology
MCA:量子计算在生物信息学和计算生物学中的应用
- 批准号:
2120949 - 财政年份:2021
- 资助金额:
$ 28.08万 - 项目类别:
Standard Grant
Predoctoral Training Program in Bioinformatics and Computational Biology
生物信息学和计算生物学博士前培训项目
- 批准号:
10641034 - 财政年份:2021
- 资助金额:
$ 28.08万 - 项目类别: